JP2009513165A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513165A5
JP2009513165A5 JP2006516183A JP2006516183A JP2009513165A5 JP 2009513165 A5 JP2009513165 A5 JP 2009513165A5 JP 2006516183 A JP2006516183 A JP 2006516183A JP 2006516183 A JP2006516183 A JP 2006516183A JP 2009513165 A5 JP2009513165 A5 JP 2009513165A5
Authority
JP
Japan
Prior art keywords
plga
weight
plasticized
temperature
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006516183A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513165A (ja
Filing date
Publication date
Priority claimed from IT001302A external-priority patent/ITMI20031302A1/it
Application filed filed Critical
Publication of JP2009513165A publication Critical patent/JP2009513165A/ja
Publication of JP2009513165A5 publication Critical patent/JP2009513165A5/ja
Pending legal-status Critical Current

Links

JP2006516183A 2003-06-26 2004-06-24 Plgaマトリックス中に分散された熱不安定性活性成分を含有する皮下インプラントを製造するための可塑剤としてのエタノールの使用 Pending JP2009513165A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001302A ITMI20031302A1 (it) 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.
PCT/EP2004/051226 WO2005000277A1 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix

Publications (2)

Publication Number Publication Date
JP2009513165A JP2009513165A (ja) 2009-04-02
JP2009513165A5 true JP2009513165A5 (enExample) 2011-05-06

Family

ID=30131301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006516183A Pending JP2009513165A (ja) 2003-06-26 2004-06-24 Plgaマトリックス中に分散された熱不安定性活性成分を含有する皮下インプラントを製造するための可塑剤としてのエタノールの使用

Country Status (17)

Country Link
US (1) US8206621B2 (enExample)
EP (1) EP1638534B1 (enExample)
JP (1) JP2009513165A (enExample)
KR (1) KR101143771B1 (enExample)
CN (1) CN100509060C (enExample)
AT (1) ATE398447T1 (enExample)
AU (1) AU2004251456B2 (enExample)
BR (1) BRPI0411759A (enExample)
CA (1) CA2530117C (enExample)
CY (1) CY1108346T1 (enExample)
DE (1) DE602004014496D1 (enExample)
ES (1) ES2308195T3 (enExample)
IT (1) ITMI20031302A1 (enExample)
MX (1) MXPA05013697A (enExample)
PL (1) PL1638534T3 (enExample)
PT (1) PT1638534E (enExample)
WO (1) WO2005000277A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
US8329203B2 (en) 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
EP1909689A4 (en) * 2005-07-18 2011-11-16 Univ Pennsylvania PHARMACEUTICAL IMPLANTS AND METHOD OF USE THEREOF
ITMI20061539A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
DE602007008125D1 (de) 2006-10-31 2010-09-09 Surmodics Pharmaceuticals Inc Kugelförmige polymer-teilchen
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
US9498431B2 (en) * 2008-12-10 2016-11-22 Jianjian Xu Controlled releasing composition
CA2804035A1 (en) * 2010-06-30 2012-01-05 Evonik Degussa Corporation Implant processing methods for thermally labile and other bioactive agents and implants prepared from same
GB201314312D0 (en) * 2013-08-09 2013-09-25 Regentec Ltd Composition and delivery system
CN103623415B (zh) * 2013-12-04 2015-03-25 北京诺康达医药科技有限公司 一种用于生物多肽制剂的plga与乙醇的复合物
EP3177319A1 (en) * 2014-08-04 2017-06-14 Janssen Sciences Ireland UC Compacted solid dosage form
GB201702475D0 (en) * 2017-02-15 2017-03-29 Locate Therapeutics Ltd Tissue scaffold and scaffold composition
EP3459527B1 (en) * 2017-09-20 2022-11-23 Tillotts Pharma Ag Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549629A (ja) * 1991-08-23 1993-03-02 Konica Corp 医用放射線画像読影装置
US5520923A (en) * 1994-09-19 1996-05-28 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
CN100446809C (zh) 2001-11-14 2008-12-31 阿尔扎有限公司 可注射的长效组合物

Similar Documents

Publication Publication Date Title
JP2009513165A5 (enExample)
LeClair et al. Optimization of spray drying conditions for yield, particle size and biological activity of thermally stable viral vectors
LV12231A (lv) Dispersa makromolekulu kompozicija
CY1118080T1 (el) Σωματιδια απελευθερωσης που ομοιαζουν με ιικα σωματιδια για αυτοαντιγραφικα rna μορια
Wijiani et al. Characterization and dissolution study of micellar curcumin-spray dried powder for oral delivery
JP2018521128A (ja) ポリマー性ベシクル中の機能性タンパク質の改善されたカプセル化のための組成物および方法
CA2530117A1 (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
Gordon et al. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery
CN102481263A (zh) 交联蛋白纳米晶体、交联蛋白纳米聚集体及其制备方法
Anumolu et al. Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery
Sarkar et al. Moistening liquid-dependent de-aggregation of microcrystalline cellulose and its impact on pellet formation by extrusion–spheronization
ATE462413T1 (de) Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
Tiwari et al. Can self-assembled hydrogels composed of aromatic amino acid derivatives function as drug delivery carriers?
ATE95984T1 (de) Verfahren zur herstellung von einem mit schneller freisetzung stabilisierten aspartambestandteil fuer kaugummis.
ES2391030T3 (es) Composiciones de almidón aglomerado
JP2005538933A5 (enExample)
CN104031210B (zh) 季铵盐表面改性的单分散聚苯乙烯微球乳液的制备方法
CN1230205C (zh) 基因制剂
JP2018140898A (ja) 無機物成形体およびその製造方法
WO1995028938A1 (en) Molten granulated sucralfate preparation and process for producing the same
KR101757890B1 (ko) 기능성 물질의 방출 제어를 위한 고분자-다공성 무기담체 복합체의 제조 방법
CN1784217B (zh) 粘结剂组合物和压缩性不良药物加工成预定硬度和脆性的片剂的方法
CN107307429A (zh) 益生菌制剂的薄膜包衣预混剂及其制备方法、应用
CN115209876A (zh) 颗粒和使用该颗粒的制剂
WO2006042284A3 (en) Toner processes and compositions thereof